CIBC Bancorp USA’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.4K Buy
16,950
+6,810
+67% +$23.7K ﹤0.01% 2174
2026
Q2
$35.4K Buy
+10,140
New +$32.7K ﹤0.01% 1901
2025
Q3
$50.5K Buy
+14,222
New +$51.4K ﹤0.01% 1413

Other funds holding SANA

CIBC Bancorp USA's SANA Position: Q3 2026 in Review

CIBC Bancorp USA increased its Sana Biotechnology (SANA) stake by 67% in Q3 2026, buying an estimated $23.7K and bringing the position to 16,950 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

CIBC Bancorp USA first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. The position peaked at $50.5K in Q3 2025. 173 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • CIBC Bancorp USA held 16,950 shares of Sana Biotechnology worth $49.4K as of Q3 2026.
  • CIBC Bancorp USA bought 6,810 Sana Biotechnology shares in Q3 2026, an estimated $23.7K.
  • Sana Biotechnology made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2174 holding.
  • CIBC Bancorp USA first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Sana Biotechnology position peaked at $50.5K in Q3 2025.
  • 173 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.